Executive summary: The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis.

Executive summary: The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis.

Published version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/387824

Files

Supporting information (667.22 KB)

Primary Published version (1000.62 KB)

Bibliographic metadata (61.57 KB)

Type

Authors

Biddle, Kathryn

https://orcid.org/0000-0001-5267-200X

Wilson-Morkeh, Harold

Adikari, Madura

Al Yaghchi, Chadwan

Abstract

Graphical Abstract:

Description

Acknowledgements: The British Thoracic Society, The UK Kidney Association, The British Laryngological Association and Vasculitis UK each endorse the 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis. A list of BSR Guideline Steering Group members can be found in Supplementary Data S1, available at Rheumatology online.

Funder: AstraZeneca; doi: https://doi.org/10.13039/100004325

Keywords

32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, 3204 Immunology, Autoimmune Disease, Cardiovascular, Inflammatory and immune system

Journal Title

Rheumatology (Oxford)

Journal ISSN

1462-0324
1462-0332

Volume Title

64

Publisher

Oxford University Press (OUP)

Publisher DOI

https://doi.org/10.1093/rheumatology/keaf242

Rights and licensing

Except where otherwised noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0/

Collections

Jisc Publications Router